Accurate, sensitive, and simple spectrophotometric and spectrofluorimetric methods were developed for the determination of gliclazide in pharmaceutical formulations and biological fluids. Both methods are based on a coupling reaction between gliclazide and 4-chloro-7-nitrobenzo-2-oxa-1,3-diazole in borate buffer, pH 7.8, in which a yellow reaction product that can be measured spectrophotometrically at 400 nm was developed. The same product exhibited a yellow fluorescence at 470 nm upon excitation at 400 nm. The absorbance-concentration plot was rectilinear over the range of 2-20 mg/mL with minimum detectability [signal-to-noise (S/N) ratio = 2] of 0.2 mg/mL (6.18´10 
. It is orally administered in the treatment of type 2 diabetes mellitus and has a duration of action of ³12 h. Because its effects are less prolonged than those of chlorpropamide or glibenclamide, it may be more suitable for elderly patients, who are prone to hypoglycemia with longer acting sulfonylureas.
Several methods have been published for the determination of GLZ, either per se or in pharmaceutical preparations and biological fluids. These methods include spectrophotometry (2) (3) (4) , radioimmunoassay (5), gas-liquid chromatography (6, 7), thin-layer chromatography (8) , and liquid chromatography (9) (10) (11) (12) (13) (14) (15) (16) . All these methods are either insufficiently sensitive (2-4) or tedious, and they require highly sophisticated and dedicated instrumentation (9) (10) (11) (12) (13) (14) (15) (16) . These conditions led us to study its reaction with 4-chloro-7-nitrobenzo-2-oxa-1,3-diazole (NBD-Cl) to develop simple and sensitive spectrofluorimetric and spectrophotometric methods for the determination of GLZ in pharmaceutical preparations and biological fluids. NBD-Cl is a useful derivatizing agent for primary amines, secondary amines, and thiols. Several pharmaceutical compounds have been determined through this approach (17) (18) (19) (20) (21) (22) .
There is no sensitive spectrofluorimetric method for the determination of GLZ; thus, there is a need for a sensitive, reliable spectrofluorimetric and spectrophotometric method for its determination in pharmaceutical formulations and biological fluids.
Experimental

Apparatus
(a) Spectrophotometer.-Shimadzu UV-Vis 1601 (Tokyo, Japan; P/N 206-67001); recording range, 0-1.0 cm; wavelengths, 400 and 226 nm.
(b) Spectrofluorometer.-Shimadzu ARF-1501 with xenon lamp. 
Materials and Reagents
Standard Solutions
A stock solution was prepared by dissolving 20.0 mg GLZ in 100 mL methanol, and further diluting with the same solvent as appropriate. The standard solutions were stable for 7 days when kept in the refrigerator.
Procedures
Spectrophotometric method.-Transfer aliquots of GLZ standard solution into a series of 10 mL volumetric flasks. Add 5 mL borate buffer (pH 7.8), and then add 0.8 mL 0.1% NBD-Cl, and mix well. Heat at 60 ± 2°C for 25 ± 2 min in thermostatically controlled water bath, and then cool. Add 0.2 mL HCl. Dilute to volume with distilled water. Measure absorbance of solution at 400 nm. Plot the measured absorbance vs final concentration to obtain calibration curve. Alternatively, derive the corresponding regression equation.
Spectrofluorimetric method.-Repeat the procedure described for spectrophotometric method after dilution of the standard solution to obtain the concentration range cited in Table 1. Measure fluorescence intensity of the solution at 470 nm after excitation at 400 nm. Plot measured fluorescence intensity vs final concentration to obtain the calibration curve. Alternatively, derive the corresponding regression equation.
Preparation of Tablet
Weigh and pulverize 20 tablets. Transfer weighed quantity of powder equivalent to 20 mg GLZ into small conical flask, and extract with 3´30 mL methanol. Filter extract into 100 mL volumetric flask. Wash conical flask with several milliliters of methanol. Pass washings into the same conical flask and dilute to volume with the same solvent. Transfer aliquots covering the working concentration range (Table 1 ) into 10 mL volumetric flasks. Proceed as described under Procedures, adopting both methods. Determine nominal content of tablets either from calibration curve or by using the corresponding regression equation.
Results and Discussion
NBD-Cl, as an electroactive halide reagent, was first introduced as an analytical reagent for the determination of some amines and amino acids (17) . In recent reports, NBD-Cl was used as a chromogenic reagent for the determination of pharmaceutical compounds (18) (19) (20) (21) (22) .
In the present study, GLZ reacted with NBD-Cl in the presence of borate buffer (pH 7.8), producing a yellow color that peaked at 400 nm ( Figure 2 ) or resulted in a strong fluorescence at 470 nm after excitation at 400 nm ( Figure 3 ). 
Study of Experimental Conditions
The spectrofluorimetric and spectrophotometric properties of the colored product and the different experimental parameters affecting the color development and its stability were carefully studied and optimized. Such factors were changed individually while others were kept constant. The factors included pH, type of buffer, temperature, time of heating, effect of sensitizers, and surfactants.
The influence of pH on the fluorescence intensity of the reaction product was evaluated. Maximum fluorescence intensity was obtained at pH 7.8, after which the fluorescence intensity of the reaction product gradually decreased to pH 9. Therefore, pH 7.8 was chosen as the optimum pH ( Figure 4 ). Other buffers having the same pH, e.g., phosphate and hexamine, were tried and compared with 0.2M borate buffer; however, borate buffer was found to be superior to those buffers because the net fluorescence intensity was higher for borate buffer, probably because the rate of hydrolysis of NBD-Cl to 4-hydroxy-7-nitrobenzo-2-oxa-1,3-diazole (NBD-OH) was much slower. This result is in agreement with that of Miyano et al. (23) .
The influence of the concentration of NBD-Cl was studied by using different volumes of 0.1% solution of the reagent. It was found that the reaction of NBD-Cl with GLZ began when 0.1 mL reagent was used in the presence of borate buffer (pH 7.8). Increasing the volume of the reagent produced a proportional increase in fluorescence intensity of the reaction product up to 0.8 mL, after which further increase in reagent volume produced a gradual decrease in fluorescence intensity. Therefore, 0.8 mL 0.1% NBD-Cl solution was chosen as the optimal volume of the reagent ( Figure 5 ).
Different temperature settings were used with constant heating time. Increasing the temperature of the water bath produced a proportional increase in fluorescence intensity of the reaction product up to boiling. Heating at a relatively lower temperature (60°C) for a longer period (25 min) was better than heating at a higher temperature for a shorter period of time, for reproducibility of fluorescence intensities.
The time of heating was an essential part of the experiment. Different intervals were tested to ascertain the time after which the solution attained its highest fluorescence. After 25 min, the reaction product reached the highest fluorescence intensity ( Figure 6 ). Heating time of 25 min was adequate, and fluorescence intensity of the reaction product was stable for about 40 min at room temperature.
The fluorescence intensity or absorbance value of the hydrolysis product of NBD-Cl, i.e., NBD-OH, was quenched by decreasing the pH of the reaction medium to <1. Therefore, acidification of the reaction mixture before measurement of fluorescence intensity or absorbance value remarkedly decreased the background fluorescence or absorbance as a result of the formation of NBD-OH without affecting the drug reagent adduct; hence the sensitivity was increased.
In a preliminary attempt to enhance the quantum yield by adding sensitizers and surfactants, positive results with lack of linearity were observed. Different sensitizers (quinine, fluorescein, and rhodamine-B) at concentrations of 5 mg/mL were added to the reactant mixture before heating, and outstanding enhancement effects were observed ( Table 2 ). The effect of surfactants on color development was also studied. Different sufactants (cetrimide, gelatin, and sodium lauryl sulfate) at 3 different concentrations (2.5, 7.5, and 15 mg/mL) were added to the reaction mixture before heating, and outstanding enhancement effects were also observed (Table 2). The increase in the absorbance and fluorescence intensities of the reaction product in micellar medium was attributed to a stabilization/protection of the excited-state singlet that hinders decay by quenching and nonradiative deactivation (24) .
Analytical Performance
The fluorescence-concentration plot was linear over the range of 0.2-2.5 mg/mL with minimum detectability [signal-to-noise (S/N) ratio = 2] of 0.02 mg/mL (6.18´10 where F is fluorescence intensity, A is absorbance in 1 cm cell, and C is the concentration of the drug in mg/mL. The limit of quantitation (LOQ) was determined by establishing the lowest concentration that can be measured and was found to be 0.2 mg/mL by the spectrofluorimetric method and 2 mg/mL by the spectrophotometric method. The limit of detection (LOD) was determined by establishing the minimum level at which the analyte can be reliably detected and was found to be (S/N = 2) 0.02 and 0.2 mg/mL by the spectrofluorimetric and spectrophotometric methods, respectively. The proposed method was evaluated by studying the accuracy as percent relative error (Table 1 ) and precision as percent relative standard deviation (RSD%; Table 3 ).
Validation of the Method
The method was tested for linearity, specificity, precision, and reproducibility. With the above fluorimetric and spectrophotometric procedures, linear regression equations were obtained. The regression plots showed a linear dependence of relative fluorescence intensity or absorbance value on drug concentration over the range cited in Table 1 . The reproducibility or precision of the method was evaluated by statistical analysis of the regression data regarding standard deviation of the residuals (S y/x ), the intercept (S a ), and the slope (S b ). The small values point out the low scattering of the calibration graph. The precision of the proposed method was evaluated by analyzing standard solutions of GLZ. The results obtained by the proposed method were compared with those given by the official nonaqueous titration method with perchloric acid used as a titrant (25) .
Statistical analysis (26) of the results, obtained by both methods and the official method using the Student's t-test and variance ratio F-test, shows no significant difference between the performance of the 2 methods for accuracy and precision, respectively ( Table 3) .
The specificity of the method was investigated by observing any interference encountered from the excipients of the tablets. These excipients did not interfere with the proposed method ( Table 4) .
Pharmaceutical Applications
The proposed method was applied to the determination of GLZ in its tablets dosage form. Common tablet excipients such as talc, lactose, starch, avisil, gelatin, and magnesium stearate did not interfere with the assay. The results were compared with those obtained by using a reference method (3). The reference method involved measurement of the absorbance of gliclazide tablets in 0.05M NaOH at 226 nm. The reference method adopted here is simple compared with the other reported chromatographic methods. Statistical analysis (26) of the results using Student's t-test and variance ratio F-test revealed no significant difference between the 2 methods at the 95% confidence level for accuracy and precision, respectively (Table 4) .
Mechanism of the Reaction
The stoichiometry of the reaction was studied by adopting the limiting logarithmic method (27) . The absorbance of the reaction product was alternatively measured in the presence of excess of NBD-Cl and GLZ. A plot of log fluorescence versus log [NBD-Cl] and log [GLZ] gave straight lines; the values of the slopes were 1.21 and 1.01, respectively ( Figure 7) . Hence, it is concluded that the molar reactivity of the reaction is 1.21/1.01, i.e., the reaction proceeds in the ratio of 1:1, confirming that one molecule of the drug condenses with one molecule of NBD-Cl. GLZ in alkaline medium undergoes enolization to give hydroxamic acid derivative. The latter reacts with NBD-Cl through its acidic hydrogen to give the following final reaction product. A schematic proposal of the reaction pathway is shown in Figure 8 .
Conclusions
Simple and sensitive methods were developed for the determination of GLZ. The spectrophotometric method can be readily adapted to analysis of dosage forms. The spectrofluorimetric method, by virtue of its high sensitivity, can be used for analysis of biological fluids; it can measure as low as 0.2 mg/mL with good accuracy. The proposed method could be used for routine quality control studies. 
